QuadMedicine, Inc. (KOSDAQ:464490)
South Korea flag South Korea · Delayed Price · Currency is KRW
13,020
+270 (2.12%)
At close: Apr 23, 2026

Revenue by Segment

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Dec '25 Dec '24 Dec '23
Biotechnology (Startups)
10.70B9.30B1.01B
Biotechnology (Startups) Growth
14.99%819.58%-
Total
10.70B9.30B1.01B
Total Growth
14.99%819.58%-

Revenue by Geography

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Dec '25 Dec '24 Dec '23
South Korea
10.18B8.46B1.01B
South Korea Growth
20.41%735.95%-
Europe
514.05M846.11M-
Europe Growth
-39.25%--
Total
10.70B9.30B1.01B
Total Growth
14.99%819.58%-
Source: S&P Global Market Intelligence.